4.7 Article

High-Performance Delivery of a CRISPR Interference System via Lipid-Polymer Hybrid Nanoparticles Combined with Ultrasound-Mediated Microbubble Destruction for Tumor-Specific Gene Repression

Journal

ADVANCED HEALTHCARE MATERIALS
Volume 12, Issue 10, Pages -

Publisher

WILEY
DOI: 10.1002/adhm.202203082

Keywords

breast cancer; CRISPR interference systems; lipid-polymer hybrid nanoparticles; miR-10b; ultrasound-mediated microbubble destruction

Ask authors/readers for more resources

In this study, a combination of pH-responsive lipid-polymer hybrid nanoparticles (PLPNs) and ultrasound-mediated microbubble destruction (UMMD) is used for the efficient delivery of the CRISPRi system. The PLPNs loaded with the CRISPRi plasmid can effectively target cancer cells and increase the time spent in circulation in vivo. Furthermore, the combination of PLPNs with UMMD achieves a higher cellular uptake and retention of the CRISPRi plasmid. When applied to breast cancer, this system effectively inhibits miR-10b and disturbs multiple cell migration and invasion-related signaling pathways, resulting in a significant inhibition of lung metastasis.
The dCas9-based CRISPR interference (CRISPRi) system efficiently silences genes without causing detectable off-target activity, thus showing great potential for the treatment of cancer at the transcriptional level. However, due to the large size of the commonly used CRISPRi system, effective delivery of the system has been a challenge that hinders its application in the clinic. Herein, a combination of pH-responsive lipid-polymer hybrid nanoparticles (PLPNs) and ultrasound-mediated microbubble destruction (UMMD) is used for the delivery of the CRISPRi system. The core-shell structure of PLPNs can effectively be loaded with the CRISPRi plasmid, and increases the time spent in the circulating in vivo, and actively target cancer cells. Moreover, the combination of PLPNs with UMMD achieves a higher cellular uptake of the CRISPRi plasmid in vitro and retention in vivo. Furthermore, when PLPNs loaded with a CRISPRi plasmid that targets microRNA-10b (miR-10b) are used in combination with UMMD, it results in the effective repression of miR-10b in breast cancer, simultaneous disturbance of multiple cell migration and invasion-related signaling pathways, and a significant inhibition of lung metastasis. Thus, the established system presents a versatile, highly efficient, and safe strategy for delivery of the CRISPRi system both in vitro and in vivo.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available